Patent details

Basic Information

Publication number:

EP3209291

PCT Application Number:

US2015056824

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP157878497

PCT Publication Number:

WO2016065103

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHOD OF TREATING CONDITIONS RELATED TO THE PGI2 RECEPTOR

French Title of Invention:

PROCÉDÉ DE TRAITEMENT DE TROUBLES LIÉS AU RÉCEPTEUR PGI2

German Title of Invention:

VERFAHREN ZUR BEHANDLUNG VON LEIDEN IM ZUSAMMENHANG MIT DEM PGI2-REZEPTOR

SPC Number:

Dates

Filing date:

22/10/2015

Grant date:

06/12/2023

EP Publication Date:

30/08/2017

PCT Publication Date:

28/04/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/12/2023

EP B1 Publication Date:

06/12/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

22/10/2024

Expiration date:

22/10/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

29/11/2023

 

 

Name:

Arena Pharmaceuticals, Inc.

Address:

66 Hudson Boulevard East, New York, NY 10001-2192, United States (US)

Inventor

Name:

GLICKLICH, Alan

Address:

United States (US)

Priority

Priority Number:

201462067916 P

Priority Date:

23/10/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/33;

Publication

European Patent Bulletin

1

Issue number:

202349

Publication date:

06/12/2023

Description:

Grant (B1)

2

Issue number:

202352

Publication date:

27/12/2023

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages